Guided Therapeutics Inc (GTHP)

[MrBruce]

Steven Derby and SDS Capital Reveal Stake in Guided Therapeutics - cbl
Posted April 24, 2011 By Richard Rabicoff

http://newyork.citybizlist.com/18/2011/4/24/Steven-Derby-and-SDS-Capital-Reveal-Stake-in-Guided-Therapeutics--cbl.aspx

NEW YORK -- Steven Derby and his SDS Capital Management, LLC reported that they own 180,403 shares or 0.39 percent of Guided Therapeutics, Inc. (OTCBB and OTCQB: GTHP).

The holdings are worth $162,362 at the Guided Therapeutics Friday closing price of $0.90 per share.

Norcross, Ga.-based Guided Therapeutics is a medical device company focused primarily on the Light Touch cervical cancer detection technology and extension of its biophotonics detection platform into other cancers, especially lung and esophageal.

For 2010, the company's revenue was approximately $3.3 million versus approximately $1.6 million for 2009. For the year, the net loss was $4.5 million, or $0.12 per share, compared to a net loss of $6.4 million, or $0.38 per share, in 2009.

Guided Therapeutics recently announced the extension of its contract with Konica Minolta Opto to develop a product that will help detect and monitor a pre-cancerous condition of the esophagus.

The company is led by Dr. Mark L. Faupel Ph.D., who serves as chief executive officer, president, chief operating officer, acting chief financial officer, and principal accounting officer.

Derby, who holds an MBA from the Stanford School of Business, started SDS Capital in 2000. The Old Greenwich, Conn.-based firm is a life sciences investment boutique that has invested in such companies as Forticell BioScience, Inc., Telenetics, Corp., Entremed, and Echo Therapeutics, Inc.